Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2484-2492

  Piroth, Lionel ^a   Martin, Laurent ^b   Coulon, Alexis ^a   Lequeu, Catherine ^a   Duong, Michel ^a   Buisson, Marielle ^a   Portier, Henri ^a   Chavanet, Pascal ^a  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; PENICILLIN G;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SCREENING; HISTOPATHOLOGY; IMMUNOCOMPETENCE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 0032847098     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2484     Document Type: Article

References (53)

1. Azoulay-Dupuis, E., J. Bedos, E. Vallée, D. J. Hardy, R. N. Swanson, and J. Pocidalo. 1991. Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. J. Infect. Dis. 163:319-324.
2. Azoulay-Dupuis, E., P. Moine, J. Bedos, V. Rieux, and E. Vallée. 1996. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains. Antimicrob. Agents Chemother. 40:941-946.
3. Azoulay-Dupuis, E., E. Vallée, B. Veber, J. Bedos, J. Bauchet, and J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother. 36:2698-2703.
4. Baker, D. 1998. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin. Microbiol. Rev. 11:231-266.
5. Bartlett, J., R. Breiman, L. Mandell, and T. File. 1998. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:811-838.
6. Bédos, J., V. Rieux, J. Bauchet, M. Muffat-Joly, C. Carbon, and E. Azoulay-Dupuis. 1996. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 40:2829-2834.
7. Bédos, J., O. Rolin, D. Bouanchaud, and J. Pocidalo. 1991. Relation entre virulence et résistance aux antibiotiques des pneumocoques. Apport des données expérimentales sur un modèle animal. Pathol. Biol. 39:984-990.
8. Briles, D. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60: 111-116.
9. Candiani, G., M. Abbondi, M. Borgonovi, and R. Williams. 1997. Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment. J. Antimicrob. Chemother. 39: 199-207.
10. Chapin-Robertson, K., and S. Edberg. 1991. Measurement of antibiotics in human body fluids: techniques and significance, p. 295-366. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, Md.
11. Corley, D., S. Kirtland, R. Winterbauer, S. Hammar, D. Dail, D. Bauermeister, and J. Bolen. 1997. Reproducibility of the histologic diagnosis of pneumonia among a panel of four pathologists - analysis of a gold standard. Chest 112:458-465.
12. Cox, A., J. Meewis, and R. Horton. 1989. Penetration into lung tissue after intravenous administration of amoxycillin/clavulanate. J. Antimicrob. Chemother. 24:S87-S91.
13. Croydon, E. A. P., and R. Sutherland. 1971. α-Amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man, p. 427-430. Antimicrob. Agents Chemother. 1970.
14. Darras-Joly, C., J. Bédos, C. Sauve, P. Moine, E. Vallee, C. Carbon, and E. Azoulay-Dupuis. 1996. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 40:2147-2151.
15. Flückiger, U., P. Moreillon, J. Blaser, M. Bickle, M. Glauser, and P. Francioli. 1994. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob. Agents Chemother. 38:2846-2849.
16. Flückiger, U., C. Segessenmann, and A. Gerber. 1991. Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model. Antimicrob. Agents Chemother. 35:1905-1910.
17. Fukuoka, T., H. Kawada, A. Kitayama, T. Koga, M. Kubota, T. Harasaki, Y. Kamai, S. Ohya, H. Yasuda, M. Iwata, and S. Kuwahara. 1998. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice. Antimicrob. Agents Chemother. 42:23-27.
18. Gavalda, J., J. A. Capdevila, B. Almirante, J. Otero, I. Ruiz, M. Laguarda, H. Allende, E. Crespo, C. Pigrau, and A. Pahissa. 1997. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats. Antimicrob. Agents Chemother. 41:795-801.
19. Gerber, A., H. Brugger, C. Feller, T. Stritzko, and B. Stadler. 1986. Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. J. Infect. Dis. 153:90-97.
20. Gerber, A., T. Stritzko, C. Segessenmann, and B. Stalder. 1991. Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model. Scand. J. Infect. Dis. 74:195-203.
21. Gould, I. M., G. Harvey, D. Golder, T. M. Reid, S. J. Watt, J. A. Friend, J. S. Legge, and J. G. Douglas. 1994. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens. Thorax 49:999-1001.
22. Greenblatt, D., and J. Koch-Weser. 1975. Clinical pharmacokinetics. N. Engl. J. Med. 297:702-705.
23. Hekster, Y., A. Baars, T. Vree, B. van Klingeren, and A. Rutgers. 1979. Comparison of the determination of β-lactam antibiotic drugs in plasma of rabbits by means of HPLC and of a microbiological assay. Pharm. Wbl. (Sci. Ed.) 1:695-700.
24. Hill, S., and K. Jones. 1980. Pharmacokinetics of parenterally administered amoxycillin. J. Infect. 2:320-332.
25. Hofmann, J., M. Cetron, M. Farley, W. Baughman, R. Facklam, J. Elliott, K. Deaver, and R. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333:481-486.
26. Hull, C., and K. McLeod. 1976. Pharmacokinetic analysis using an electrical analogue. Br. J. Anaesth. 48:677-686.
27. Hull, C. J. 1984. General principles of pharmacokinetics, p. 1-24. In C. Prys-Roberts and C. Hug (ed.), Pharmacokinetics of anesthesia. Blackwell, Oxford, England.
28. Kirtland, S., D. Corley, R. Winterbauer, S. Springmeyer, K. Casey, N. Hampson, and D. Dreis. 1997. The diagnosis of ventilator-associated pneumonia - a comparison of histologic, microbiologic, and clinical criteria. Chest 112:445-457.
29. Knapp, B., and T. Kent. 1968. Postmortem lung cultures. Arch. Pathol. 85: 200-203.
30. Labaune, J. 1988. Pharmacocinétique, 2nd ed. Masson, Paris, France.
31. Marquette, C., F. Wallet, M. Copin, D. Wermet, A. Desmidt, P. Ramon, R. Courcol, and A. Tonnel. 1996. Relationship between microbiologic and histologic features in bacterial pneumonia. Am. J. Respir. Crit. Care Med. 154: 1784-1787.
32. Menten, M., S. Bailey, and F. DeBone. 1932. Pneumonia in children. J. Infect. Dis. 51:254-267.
33. Moine, P., C. Sauve, E. Vallee, J. Bedos, and E. Azoulay-Dupuis. 1997 In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin-cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Clin. Microbiol. Infect. 3: 608-615.
34. Moine, P., E. Vallée, E. Azoulay-Dupuis, P. Bourget, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
35. Moine, P., J. Vercken, S. Chevret, and P. Gajdos. 1995. Severe community-acquired pneumococcal pneumonia. Scand. J. Infect. Dis. 27:201-206.
36. Nava, J. M., F. Bella, J. Garau, J. Lite, M. Morera, C. Marti, D. Fontanals, B. Font, V. Pineda, S. Uriz, F. Deulofeu, A. Calderon, P. Duran, M. Grau, and A. Agudo. 1994. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. J. Infect. Dis. 19:884-890.
37. Pallares, R., J. Lineares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
38. Percy, D. H., J. L. Bhasin, and S. Rosendal. 1986. Experimental pneumonia in rabbits inoculated with strains of Pasteurella multocida. Can. J. Vet. Res. 50:36-41.
39. Ponte, C., A. Parra, E. Nieto, and F. Soriano. 1996. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime. and meropenem. Antimicrob. Agents Chemother. 40:2698-2702.
40. Rouby, J., E. Martin de Lassale, P. Poete, M. Nicolas, L. Bodin, V. Jarlier, Y. Le Charpentier, J. Grosset, and P. Viars. 1992. Nosocomial bronchopneumonia in the critically ill. Am. Rev. Respir. Dis. 146:1059-1066.
41. Saladino, R., A. Stack, G. Fleisher, C. Thompson, D. Briles, L. Kobzik, and G. Siber. 1997. Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats. Infect. Immun. 65:4701-4704.
42. Sauve, C., E. Azoulay-Dupuis, P. Moine, V. Darras-Joly, V. Rieux, C. Carbon, and J. Bêdos. 1996. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40: 2147-2151.
43. Smith, G. M., and K. H. Abbott. 1994. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or β-lactamase-producing Haemophilus influenzae. Antimicrob. Agents Chemother. 38:608-610.
44. Société de Pathologie Infectieuse de Langue Française (SPILF). 1992. Quatrième conférence de consensus sur le traitement des infections respiratoires. Med. Mal. Infect. 22:44-47.
45. Takashima, K., K. Tateda, T. Matsumoto, T. Ito, Y. Iizawa, M. Nakao, and K. Yamaguchi. 1996. Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice. J. Med. 45:319-322.
46. Tateda, K., K. Takashima, H. Miyazaki, T. Matsumoto, T. Hatori, and K. Yamaguchi. 1996. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob. Agents Chemother. 40:1520-1525.
47. Thompson, R., J. Ruegsegger, M. Blankenhorm, and M. Hamburger. 1951. Primary pneumococcic pneumonia in the Cincinnati General Hospital, 1936-1950. J. Lab. Clin. Med. 37:73-87.
48. Tilghman, R., and M. Finland. 1937. Clinical significance of bacteremia in pneumococcic pneumonia. Arch. Intern. Med. 59:602-619.
49. Torres, A., M. El-Ebiary, L. Padro, J. Gonzales, J. Puig de la Belcasa, J. Ramirez, A. Xaubet, M. Ferrer, and R. Rodriguez-Roisin. 1994. Validation of different techniques for the diagnosis of ventilator-associated pneumonia: comparison with immediate postmortem pulmonary biopsy. Am. J. Respir. Crit. Care Med. 149:324-331.
50. Walsh, T., J. Bacher, and P. A. Pizzo. 1988. Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. Lab. Anim. Sci. 38:467-471.
51. Watanakunakorn, C., and T. Bailey. 1997. Adult bacteremic pneumococcal pneumonia in a community hospital, 1992-1996. Arch. Intern. Med. 157: 1965-1971.
52. Woodnutt, G., V. Berry, and L. Mizen. 1992. Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections. Antimicrob. Agents Chemother. 36:1427-1431.
53. Woodnutt, G., E. Catherall, I. Kernutt, and L. Mizen. 1988. Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum. Antimicrob. Agents Chemother. 32:1705-1709.